Fresenius Medical Care AG FMCQF
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if FMCQF is a good fit for your portfolio.
News
-
Who's afraid of Ozempic? From restaurants to package makers, companies work to calm investors' GLP-1 jitters.
-
U.S. stocks score fourth day of gains after Fed minutes, wholesale inflation data
-
Dialysis-company stocks slide after Ozempic trial's success in treating kidney disease
-
Fresenius Shares Slump After Novo Nordisk Kidney Disease Trial Shows Efficacy
Trading Information
- Previous Close Price
- $38.45
- Day Range
- $41.90–41.90
- 52-Week Range
- $34.33–49.86
- Bid/Ask
- $38.00 / $46.21
- Market Cap
- $12.29 Bil
- Volume/Avg
- 1,000 / 691
Key Statistics
- Price/Earnings (Normalized)
- 18.78
- Price/Sales
- 0.54
- Dividend Yield (Trailing)
- 3.15%
- Dividend Yield (Forward)
- 3.34%
- Total Yield
- 3.15%
Company Profile
Fresenius Medical Care is the largest dialysis company in the world, treating about 345,000 patients from over 4,100 clinics across the globe as of December 2022. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market and benefits from being the world's only fully integrated dialysis business. Services account for roughly 80% of firmwide revenue, including care coordination and ancillary operations, while products account for the other roughly 20%. Products typically enjoy a higher margin, making them a strong contributor to the bottom line.
- Sector
- Healthcare
- Industry
- Medical Care Facilities
- Stock Style Box
- Mid Core
- Total Number of Employees
- 119,845
Competitors
Valuation
|
Metric
|
FMCQF
|
FRE
|
DVA
|
|---|---|---|---|
Price/Earnings (Normalized) | 18.78 | 6.22 | 16.48 |
Price/Book Value | 0.75 | 0.82 | 11.62 |
Price/Sales | 0.54 | 0.70 | 1.06 |
Price/Cash Flow | 5.04 | 9.21 | 6.90 |
Price/Earnings
FMCQF
FRE
DVA
Financial Strength
|
Metric
|
FMCQF
|
FRE
|
DVA
|
|---|---|---|---|
Quick Ratio | 0.92 | 0.64 | 1.06 |
Current Ratio | 1.42 | 1.34 | 1.19 |
Interest Coverage | 3.22 | 2.12 | 3.95 |
Quick Ratio
FMCQF
FRE
DVA
Profitability
|
Metric
|
FMCQF
|
FRE
|
DVA
|
|---|---|---|---|
Return on Assets (Normalized) | 2.46% | 2.15% | 6.40% |
Return on Equity (Normalized) | 6.26% | 7.52% | 112.35% |
Return on Invested Capital (Normalized) | 3.93% | 3.57% | 10.05% |
Return on Assets
FMCQF
FRE
DVA
Medical Care Facilities Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
HCA
| HCA Healthcare Inc | Fyqcgmxzb | Dnhsxgv | $82.4 Bil | |
FSNUF
| Fresenius SE & Co KGaA | — | Bnychwr | $16.7 Bil | |
FSNUY
| Fresenius SE & Co KGaA ADR | — | Rllnwr | $16.7 Bil | |
BDUUY
| Bangkok Dusit Medical Services PCL ADR | — | Qrs | $12.3 Bil | |
FMS
| Fresenius Medical Care AG ADR | Bpmk | Qlqsl | $12.1 Bil | |
DVA
| DaVita Inc | Pvsndxvp | Pxzlrdw | $12.1 Bil | |
UHS
| Universal Health Services Inc Class B | — | Tzyhrl | $11.4 Bil | |
THC
| Tenet Healthcare Corp | Pgrcchhz | Pdrk | $9.8 Bil | |
AMN
| AMN Healthcare Services Inc | Svftlrfdl | Dvpvss | $2.3 Bil |